186 related articles for article (PubMed ID: 28164176)
1. BRCA1 Mutation Leads to Deregulated Ubc9 Levels which Triggers Proliferation and Migration of Patient-Derived High Grade Serous Ovarian Cancer and Triple Negative Breast Cancer Cells.
Xu J; Footman A; Qin Y; Aysola K; Black S; Reddy V; Singh K; Grizzle W; You S; Moellering D; Reddy ES; Fu Y; Rao VN
Int J Chronic Dis Ther; 2016; 2(3):31-38. PubMed ID: 28164176
[TBL] [Abstract][Full Text] [Related]
2. A novel Ubc9 -dependent pathway regulates SIRT1- ER-α Axis and BRCA1-associated TNBC lung metastasis.
Xu J; Shumate C; Qin Y; Reddy V; Burnam Y; Lopez V; Okoli J; P Reddy ES; Rao VN
Integr Mol Med; 2017 Aug; 4(4):. PubMed ID: 31341634
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 proteins regulate growth of ovarian cancer cells by tethering Ubc9.
Qin Y; Xu J; Aysola K; Oprea G; Reddy A; Matthews R; Okoli J; Cantor A; Grizzle WE; Partridge EE; Reddy ES; Landen C; Rao VN
Am J Cancer Res; 2012; 2(5):540-8. PubMed ID: 22957306
[TBL] [Abstract][Full Text] [Related]
4. Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer.
Lønning PE; Nikolaienko O; Pan K; Kurian AW; Eikesdal HP; Pettinger M; Anderson GL; Prentice RL; Chlebowski RT; Knappskog S
JAMA Oncol; 2022 Nov; 8(11):1579-1587. PubMed ID: 36074460
[TBL] [Abstract][Full Text] [Related]
5. A Novel Pathway that Links Caveolin-1 Down-Regulation to BRCA1 Dysfunction in Serous Epithelial Ovarian Cancer Cells.
Xu J; Agyemang S; Qin Y; Aysola K; Giles M; Oprea G; O'Regan RM; Partridge EE; Harris-Hooker S; Rice VM; Reddy ES; Rao VN
Enliven Chall Cancer Detect Ther; 2014; 1(1):. PubMed ID: 25594072
[TBL] [Abstract][Full Text] [Related]
6. A Provocative Molecular Link between Mammographic Density and BRCA1-loss associated TNBC.
Xu J; Olusola G; Footman A; Hansen N; Cheriyan AM; Koganti K; Reddy V; Yezdani S; Eddy V; De'smond H; Bakinde N; Okoli J; Oprea G; Gundry K; Reddy ESP; Rao VN
Int J Hum Genet Genet Disord; 2019; 1(1):1-8. PubMed ID: 33860286
[TBL] [Abstract][Full Text] [Related]
7. Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins.
Qin Y; Xu J; Aysola K; Begum N; Reddy V; Chai Y; Grizzle WE; Partridge EE; Reddy ES; Rao VN
J Cell Physiol; 2011 Dec; 226(12):3355-67. PubMed ID: 21344391
[TBL] [Abstract][Full Text] [Related]
8. A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells.
Xu J; Watkins T; Reddy A; Reddy ES; Rao VN
Int J Oncol; 2009 Apr; 34(4):939-49. PubMed ID: 19287951
[TBL] [Abstract][Full Text] [Related]
9. An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers.
Przybytkowski E; Davis T; Hosny A; Eismann J; Matulonis UA; Wulf GM; Nabavi S
BMC Cancer; 2020 Mar; 20(1):197. PubMed ID: 32164626
[TBL] [Abstract][Full Text] [Related]
10. Molecular Mechanism Linking BRCA1 Dysfunction to High Grade Serous Epithelial Ovarian Cancers with Peritoneal Permeability and Ascites.
Desai A; Xu J; Aysola K; Akinbobuyi O; White M; Reddy VE; Okoli J; Clark C; Partridge EE; Childs E; Beech DJ; Rice MV; Reddy E; Rao VN
J Gynecol Res; 2015; 1(1):. PubMed ID: 26665166
[TBL] [Abstract][Full Text] [Related]
11. Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences.
Serio PAMP; de Lima Pereira GF; Katayama MLH; Roela RA; Maistro S; Folgueira MAAK
Cells; 2021 Dec; 10(12):. PubMed ID: 34944094
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of Carboplatinum- and Taxol-Resistant High-Grade Serous Ovarian Cancer Cells Carrying p53, BRCA1/2 Mutations by Emblica officinalis (Amla) via Multiple Targets.
De A; De A; Sharma R; Suo W; Sharma M
J Cancer; 2020; 11(7):1927-1939. PubMed ID: 32194804
[No Abstract] [Full Text] [Related]
13. Clinicopathological and molecular significance of Sumolyation marker (ubiquitin conjugating enzyme 9 (UBC9)) expression in breast cancer of black women.
Agboola AO; Musa AA; Ayoade BA; Banjo AA; Anunobi CC; Deji-Agboola AM; Rakha EA; Nolan C; Ellis IO; Green AR
Pathol Res Pract; 2014 Jan; 210(1):10-7. PubMed ID: 24176171
[TBL] [Abstract][Full Text] [Related]
14. Classification of High-Grade Serous Ovarian Carcinoma by Epithelial-to-Mesenchymal Transition Signature and Homologous Recombination Repair Genes.
Sohn MH; Kim SI; Shin JY; Kim HS; Chung HH; Kim JW; Lee M; Seo JS
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356119
[TBL] [Abstract][Full Text] [Related]
15. Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer.
Phuah SY; Looi LM; Hassan N; Rhodes A; Dean S; Taib NA; Yip CH; Teo SH
Breast Cancer Res; 2012 Nov; 14(6):R142. PubMed ID: 23116406
[TBL] [Abstract][Full Text] [Related]
16. Germline and tumor
Ji G; Yao Q; Bao L; Zhang J; Bai Q; Zhu X; Tu X; Bi R; Zhou X
Ann Transl Med; 2021 Mar; 9(6):453. PubMed ID: 33850850
[TBL] [Abstract][Full Text] [Related]
17. High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients.
Rashid MU; Muhammad N; Bajwa S; Faisal S; Tahseen M; Bermejo JL; Amin A; Loya A; Hamann U
BMC Cancer; 2016 Aug; 16(1):673. PubMed ID: 27553291
[TBL] [Abstract][Full Text] [Related]
18. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.
Burga LN; Hu H; Juvekar A; Tung NM; Troyan SL; Hofstatter EW; Wulf GM
Breast Cancer Res; 2011 Mar; 13(2):R30. PubMed ID: 21396117
[TBL] [Abstract][Full Text] [Related]
19. Strong founder effect for BRCA1 c.3629_3630delAG pathogenic variant in Chechen patients with breast or ovarian cancer.
Sokolenko AP; Sultanova LV; Stepanov IA; Romanko AA; Venina AR; Sokolova TN; Musayeva HS; Tovgereeva MY; Magomedova MK; Akhmatkhanov KU; Vagapova EI; Suleymanov EA; Vasilyeva EV; Bakaeva EK; Bizin IV; Aleksakhina SN; Imyanitov EN
Cancer Med; 2023 Feb; 12(3):3167-3171. PubMed ID: 36000185
[TBL] [Abstract][Full Text] [Related]
20. Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia.
Mahfoudh W; Bettaieb I; Ghedira R; Snoussi K; Bouzid N; Klayech Z; Gabbouj S; Remadi Y; Hassen E; Bouaouina N; Zakhama A
J Transl Med; 2019 Apr; 17(1):123. PubMed ID: 30975216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
